Advancing our partners’ discovery and chemistry activities
Promidis is a subsidiary company of the IRBM Group, established in 2013 within the IRBM campus in Pomezia (Rome) and then relocated to Milan in November 2015. It is currently based in the San Raffaele Hospital Science Park (SRSI) an internationally recognized center of excellence in biomedical research.
The main objective of the company is the identification of innovative drugs in areas of high unmet medical need.
The privileged location of Promidis, within the campus of the SRSI, allows a beneficial synergy between Promidis’s drug discovery expertise and the cutting-edge pre-clinical and clinical research activities occurring at the SRSI.
Promidis is composed of experienced medicinal chemistry researchers with recognized competence in drug discovery, from early phase to late lead optimization. The team has broad experience in organic synthesis, process chemistry, and analytical chemistry activities.
Promidis specializes in supporting chemistry for drug discovery, with a strong focus on synthesis and process chemistry. This includes the design of alternative synthetic routes, useful in process chemistry development.
The Promidis Labs are based in the San Michele Tower and include 6 state-of-the-art equipped synthetic chemistry labs, and 3 analytical labs.